original ) (raw )Cost-effectiveness analysis of Helicobacter pylori screening in prevention of gastric cancer in Chinese
Toshio Tamamuro
International Journal of Technology Assessment in Health Care, 2008
View PDFchevron_right
Modelling cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer: a mandate for clinical trials
Julie Parsonnet
Lancet, 1996
View PDFchevron_right
Cost-Effectiveness of Screening With Polymerase Chain Reaction For Helicobacter Pylori To Prevent Gastric Cancer And Peptic Ulcers
Han Truong
2021
View PDFchevron_right
A large randomised controlled intervention trial to prevent gastric cancer by eradication of Helicobacter pylori in Linqu County, China: baseline results and factors affecting the eradication
Kai-feng Pan , Markus Gerhard
Gut, 2015
View PDFchevron_right
Screening and eradication of Helicobacter pylori for gastric cancer prevention: the Taipei global consensus
Wei-lun Chang
Gut, 2020
View PDFchevron_right
Differential Helicobacter pylori infection rates in two contrasting gastric cancer risk regions of South China: H. pylori and gastric cancer in China
bw chen
Journal of Gastroenterology and Hepatology, 2002
View PDFchevron_right
Clinical Aspects of Gastric Cancer and Helicobacter pylori- Screening, Prevention, and Treatment
Michael Selgrad , Jan Bornschein
Helicobacter, 2010
View PDFchevron_right
The benefit of mass eradication of Helicobacter pylori infection: a community-based study of gastric cancer prevention
Jawtown Lin
Gut, 2013
View PDFchevron_right
Effects of Helicobacter pylori treatment on gastric cancer incidence and mortality in subgroups
Mitchell Gail
Journal of the National Cancer Institute, 2014
View PDFchevron_right
Differential Helicobacter pylori infection rates in two contrasting gastric cancer risk regions of South China
Shiu Kum Lam
Journal of Gastroenterology and Hepatology, 2002
View PDFchevron_right
Cost–benefit analysis of Helicobacter pylori screening
Arto Salomaa
Health Policy, 2004
View PDFchevron_right
Helicobacter pylori and Clinical Aspects of Gastric Cancer
Michael Selgrad , Jan Bornschein
Helicobacter, 2009
View PDFchevron_right
Clinical Characteristics and Helicobacter pylori Status of Gastric Cancer in Thailand
Surasak Aekpongpaisit
Asian Pacific Journal of Cancer Prevention, 2014
View PDFchevron_right
Gastric cancer mortality in a high incidence area: long-term follow-up of Helicobacter pylori-related precancerous lesions in the general population
Majid Boreiri
Arch Iran Med
View PDFchevron_right
Prevalence of Helicobacter Pylori in gastric cancer in a South-east Asian Population by 14 C-Urea breath test
Pierce Chow
ANZ Journal of Surgery, 2001
View PDFchevron_right
The effect of eradication of Helicobacter pylori on gastric cancer prevention in healthy asymptomatic populations
Hwoon-yong Jung
Helicobacter, 2018
View PDFchevron_right
Helicobacter pylori blood biomarker for gastric cancer risk in East Asia
Keun-young Yoo
International journal of epidemiology, 2016
View PDFchevron_right
Incidence of helicobacter pylori infection and gastric cancer : an 8-year hospital based study
Sutisna Himawan
Acta medica Indonesiana
View PDFchevron_right
The cost-effectiveness of population Helicobacter pylori screening and treatment: a Markov model using economic data from a randomized controlled trial
Richard Feltbower
Alimentary Pharmacology and Therapeutics, 2002
View PDFchevron_right
Eradication rate of Helicobacter pylori in a Mexican population at high risk for gastric cancer and use of serology to assess cure
Julie Parsonnet
American Journal of Gastroenterology, 2002
View PDFchevron_right
Helicobacter pylori eradication therapy to prevent gastric cancer in healthy asymptomatic infected individuals: systematic review and meta-analysis of randomised controlled trials
Yuhong Yuan
2014
View PDFchevron_right
Gastric Cancer Risk Diagnosis and Prevention in Subjects with Helicobacter pylori-related Chronic Gastritis
Hideyuki Tamai
Gastritis and Gastric Cancer - New Insights in Gastroprotection, Diagnosis and Treatments, 2011
View PDFchevron_right
Gastric Cancer Risk in Helicobacter Pylori Infected Patients: A Systematic Overview
Vinod Kaul
2015
View PDFchevron_right
Helicobacter pylori infection reduces likelihood of death from advanced cancer: A longitudinal analysis from the Japanese DAIKO prospective cohort study
Rafaat Technology
2021
View PDFchevron_right
1500. Gastric Carcinoma Survival Related with Helicobacter pylori Infection in Cali, Colombia: A Hospital-Based Cancer Study
Luis Bravo
Open Forum Infectious Diseases, 2019
View PDFchevron_right
Helicobacter pylori infection-negative gastric cancer in Japanese hospital patients: Incidence and pathological characteristics
Takashi Tajiri
Cancer Science, 2007
View PDFchevron_right
Helicobacter pylori and the prevention of gastric cancer
Fred Ashbury
Canadian journal of gastroenterology = Journal canadien de gastroenterologie, 2004
View PDFchevron_right
Helicobacter pylori and Gastric Cancer: What Are the Benefits of Screening Only for the CagA Phenotype of H. pylori?
Julie Parsonnet
Helicobacter, 1999
View PDFchevron_right
Serum antibodies to Helicobacter pylori and the CagA antigen do not explain differences in the prevalence of precancerous gastric lesions in two Chinese populations with contrasting gastric cancer rates
Guillermo Perez Perez
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2002
View PDFchevron_right